Tembexa
Product Images NDC 79622-010

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tembexa (NDC 79622-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chimerix, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Chemical structure diagram of the active ingredient for Tembexa by Chimerix, Inc., showing its molecular arrangement including nitrogen, oxygen, phosphorus atoms, and hydrocarbon chains.*

FDA Label Image

Principal Display Panel (Blister Carton Label)

Tembexa 100 mg per tablet package label includes the proprietary name, active ingredient brincidofovir, and directions for oral use. The label indicates a count of 4 tablets in a child-resistant wallet package. It provides dosage and administration instructions, storage conditions, and manufacturer information for Chimerix, Inc. The label also includes a barcode and usage instructions for opening the package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.